Opening https://www.businesswire.com/news/home/20240325308786/en/Edgewood-Oncology-Emerges-From-Stealth-with-20-Million-in-Series-A-Financing-to-Advance-BTX-A51-in-Patients-with-Hematologic-Malignancies-and-Genetically-Defined-Solid-Tumors